
Asthvinayak Pharmaceutical Private Limited
About Asthvinayak Pharmaceutical Private Limited
Data last updated:
Asthvinayak Pharmaceutical Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2013PTC198898. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Narendra Joshi and Raj Kumar Joshi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 2 Nyayaratna Lane, Kolkata, West Bengal, India – 700004.
As per the financials filed for FY 2024, the company reported a revenue of ₹33,590. For the same year it recorded a net loss of ₹1,771 (net margin -5.3%) and EBITDA of ₹18,266 (EBITDA margin 54.4%). Revenue has declined at a compounded annual rate (CAGR) of 44% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Asthvinayak Pharmaceutical Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2 Nyayaratna Lane, Kolkata, West Bengal, India – 700004
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Asthvinayak Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Asthvinayak Pharmaceutical Private Limited
FY 2024 filings availableAsthvinayak Pharmaceutical Private Limited reported revenue of ₹33,590 for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 44% over five years. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18,266 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,771 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 54.4% | ||||
| Net Profit Margin | -5.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Asthvinayak Pharmaceutical Private Limited, buy the company report.
Board of directors of Asthvinayak Pharmaceutical Private Limited
Asthvinayak Pharmaceutical has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narendra Joshi Also directs: Fine Health Private Limited | Director | 01 Dec 2021 | 4 Years 11 Months | Current |
| Raj Kumar Joshi Also directs: Fine Health Private Limited, Plentiful Distributors Private Limited, Shraddha Suppliers Private Limited and 2 more | Director | 04 Dec 2020 | 5 Years 11 Months | Current |
Auditor
Asthvinayak Pharmaceutical Private Limited is audited by SANTOSH KUMAR SINGH & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANTOSH KUMAR SINGH & ASSOCIATES | FY 2017 | 327476E |
Shareholding
The shareholding of Asthvinayak Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Asthvinayak Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Asthvinayak Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Asthvinayak Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Asthvinayak Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Asthvinayak Pharmaceutical Private Limited, buy the company report.
Recent activity
Asthvinayak Pharmaceutical Private Limited has 7 board changes on record since 2015: 2 appointments and 5 cessations. The latest: Narendra Joshi was appointed as Director on 01 Dec 2021.
Frequently asked questions
Asthvinayak Pharmaceutical is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 December 2013 (13+ years old) and is registered under CIN U24100WB2013PTC198898.
Asthvinayak Pharmaceutical has 2 current directors:
- Narendra Joshi - Director
- Raj Kumar Joshi - Director
The latest financial statements of Asthvinayak Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Asthvinayak Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Asthvinayak Pharmaceutical is U24100WB2013PTC198898. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Asthvinayak Pharmaceutical was incorporated on 09 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kolkata.
Narendra Joshi was appointed as Director on 01 Dec 2021. Niraj Thakur ceased to be Director on 01 Dec 2021. Chandan Kumar Singh ceased to be Director on 18 Dec 2020. Asthvinayak Pharmaceutical has 7 board changes on record in total.
The registered office of Asthvinayak Pharmaceutical is at 2 Nyayaratna Lane, Kolkata, West Bengal, India – 700004.
Asthvinayak Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Asthvinayak Pharmaceutical is compliant as of 04 September 2026. The company is actively filing with the Registrar of Companies.

